The Cole Memo

In this episode of The Cole Memo, Cole breaks down a press release from MMJ BioPharma that’s shaking up the cannabis world. The company accuses the DEA of obstruction, selective enforcement, and unconstitutional practices—and it has people speculating that federal rescheduling might finally be near. But will it actually help? Cole analyzes what’s in the press release, highlights comments from AG Pam Bondi, and plays clips from MMJ’s CEO via The Dales Report. Plus, what might DEA Administrator nominee Terrence Cole’s past statements reveal about what’s next? It’s a timely, cautious conversation about what reform might actually look like.

• Watch the episode on Youtube here
• Stream the episode on Soundcloud here
• Stream the episode on Spotify here
• Stream the episode on Apple Podcast here
• Stream the episode on X here

Links mentioned during show

• TwoDopeDudes Podcast
  • https://thecolememo.com/2025/06/04/e206/ 
• https://www.newswire.com/news/dea-in-marijuana-crisis-calls-for-termination-of-key-officials-amid-22584892 
• https://www.youtube.com/live/N_1VkYsyLC0?si=uTy9QKN9fD273rBt
• Trump Wants To Delete State Medical Marijuana Protections From Budget While Continuing To Block Cannabis Sales Legalization In D.C. 
  • Rohrabacher Farr amendment
    • https://en.wikipedia.org/wiki/Rohrabacher%E2%80%93Farr_amendment
• Terrence Cole’s post on LinkedIn